Guillain-Barré syndrome (GBS) is an acute inflammatory neuropathy that can lead to severe weakness of the limbs, face, and respiratory muscles. Its pathophysiology involves autoantibodies that attack ...

Monthly IVIG reduced grade ≥2 infections from 100% pre-treatment to 33% post-treatment, yielding a 67% relative and absolute risk reduction with strong statistical significance. Baseline IgG and IgA ...

Measuring antibody levels in the blood could be used to detect a person's heart attack risk after researchers, part-funded by the British Heart Foundation (BHF), discovered that higher levels of these ...

Please provide your email address to receive an email when new articles are posted on . Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing ...

BHV-1300 reduced total IgG by up to 84% in a four-week Phase 1 study. The treatment was well-tolerated, with no serious adverse events reported. Get access to the leaderboards pointing to tomorrow’s ...

Vaccines have been heralded as the only way out from the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This ...

Please provide your email address to receive an email when new articles are posted on . Belimumab after rituximab reduces serum IgG anti-double-stranded DNA antibody levels and the risk for severe ...